Stockscreener 앱 받기
7.24
6.22%
-0.48
시간 외 거래:
7.24
전일 마감가:
$7.72
열려 있는:
$7.58
하루 거래량:
361.40K
Relative Volume:
1.16
시가총액:
$189.34M
수익:
$47.26M
순이익/손실:
$-58.48M
주가수익비율:
-2.6766
EPS:
-2.7049
순현금흐름:
$-40.45M
1주 성능:
+4.32%
1개월 성능:
-1.50%
6개월 성능:
-52.02%
1년 성능:
-9.16%
1일 변동 폭
$7.03
$7.67
1주일 범위
$6.882
$7.835
52주 변동 폭
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
명칭
Cvrx Inc
전화
(763) 416-2850
주소
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
CVRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
7.24 | 195.81M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
129.28 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.15 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.52 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
91.98 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.18 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-01-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 재확인 | Lake Street | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2024-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Lake Street | Buy |
| 2022-07-18 | 개시 | Craig Hallum | Buy |
| 2021-07-26 | 개시 | Canaccord Genuity | Buy |
| 2021-07-26 | 개시 | Piper Sandler | Overweight |
| 2021-07-26 | 개시 | William Blair | Outperform |
모두보기
Cvrx Inc 주식(CVRX)의 최신 뉴스
How CVRx Inc. stock performs during market volatilityDouble Capital Strategy Picks - thegnnews.com
CVRx at Canaccord Genuity’s Conference: Strategic Shifts in Focus By Investing.com - Investing.com South Africa
CVRx at Canaccord Genuity’s Conference: Strategic Shifts in Focus - Investing.com
Cantor Fitzgerald reiterates Overweight rating on CVRx stock amid growth By Investing.com - Investing.com Australia
Cantor Fitzgerald reiterates Overweight rating on CVRx stock amid growth - Investing.com
Why CVRX stock attracts strong analyst attentionRisk-Reward Optimized Picks - thegnnews.com
Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Second-Quarter Report - simplywall.st
Earnings Update: CVRx, Inc. (NASDAQ:CVRX) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
CVRx outlines $55M-$57M revenue target for 2025 as sales force transition nears completion - MSN
CVRx 2025 Q2 Earnings Slight Earnings Improvement Amid Sustained Losses - AInvest
CVRx, Inc. (NASDAQ:CVRX) Q2 2025 Earnings Call Transcript - Insider Monkey
CVRx Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Cvrx, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
CVRx Appoints Brent Binkowski as New COO - The Globe and Mail
CVRx, Inc. shares fall 16.03% intraday after reporting wider-than-expected Q2 loss and lowering full-year revenue guidance. - AInvest
New Analyst Forecast: $CVRX Given 'Overweight' Rating - Quiver Quantitative
CVRx, Inc. SEC 10-Q Report - TradingView
CVRx revenue up 15% to USD 13.6M in Q2 2025 - Medical Buyer
CVRx Inc Reports 15% Revenue Growth, Expands Network, and Faces Challenges Amidst Strategic Expansion - AInvest
CVRx Inc (CVRX) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Strategic Expansion and ... By GuruFocus - Investing.com Canada
CVRx: Q2 Earnings Snapshot - Connecticut Post
CVRx, Inc. Reports Strong Q2 2025 Growth - TipRanks
CVRx Expects Q3 Revenue of $13.7M-$14.7M, Below Consensus of $14.54M. - AInvest
CVRx (CVRX) Q2 Revenue Jumps 15% - The Globe and Mail
CVRx Revenue Grows As Barostim Expansion Gains Momentum - Finimize
CVRx Grows Revenue And Expands Barostim Reach In Q2 - Finimize
CVRx Q2 2025 Earnings Call Transcript - MarketBeat
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates - sharewise.com
Earnings call transcript: CVRx Q2 2025 results show revenue growth By Investing.com - Investing.com Canada
Earnings call transcript: CVRx Q2 2025 results show revenue growth - Investing.com India
CVRx Inc. Q2 Earnings Report: Missed Expectations but Revenue Surpasses ForecastNews and Statistics - IndexBox
CVRx earnings missed by $0.05, revenue topped estimates - Investing.com Canada
CVRx Reports Second Quarter 2025 Financial and Operating Results - The Manila Times
Medical device maker CVRx beats Q2 revenue expectations - MarketScreener
CVRx, Inc. Reports 15% Revenue Growth in Q2 2025 and Announces New COO Appointment - Quiver Quantitative
CVRx Earnings: Heart Device Revenue Surges 15% with Medicare Payment Update for Barostim Technology - Stock Titan
When is CVRx Inc. stock expected to show significant growthFree Investment Community - Jammu Links News
How volatile is CVRx Inc. stock compared to the marketGet daily expert analysis for smarter investing - Jammu Links News
What is the dividend policy of CVRX stockTrack top-performing stocks in real-time - Jammu Links News
Is it the right time to buy CVRx Inc. stockBreakthrough capital growth - Jammu Links News
What makes CVRx Inc. stock price move sharplyUnstoppable investment returns - Jammu Links News
Why is CVRX stock attracting strong analyst attentionBuild wealth with reliable stock picks - Jammu Links News
What are the latest earnings results for CVRx Inc.Maximize your returns with portfolio optimization - Jammu Links News
What drives CVRX stock priceInvest confidently with data-driven strategies - Jammu Links News
What are CVRx Inc. company’s key revenue driversBuild a winning investment strategy - Jammu Links News
What institutional investors are buying CVRx Inc. stockPowerful profit generation - Jammu Links News
What are CVRX company’s key revenue driversExplosive earning power - Jammu Links News
How does CVRx Inc. compare to its industry peersHigh-octane investment opportunities await - Jammu Links News
What catalysts could drive CVRX stock higher in 2025Unlock expert stock analysis and alerts - Jammu Links News
Cvrx Inc (CVRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cvrx Inc 주식 (CVRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. | Director |
May 13 '25 |
Buy |
5.29 |
101,413 |
536,313 |
1,837,968 |
| Nielsen Kirk G. | Director |
May 14 '25 |
Buy |
5.23 |
61,200 |
320,364 |
1,899,168 |
| Nielsen Kirk G. | Director |
May 12 '25 |
Buy |
4.79 |
25,200 |
120,670 |
1,736,555 |
| Jain Mudit K. | Director |
May 12 '25 |
Buy |
4.66 |
1,500 |
6,986 |
4,900 |
| Jain Mudit K. | Director |
May 13 '25 |
Buy |
5.26 |
150 |
789 |
5,050 |
| Hykes Kevin | PRES & CEO |
May 12 '25 |
Buy |
4.84 |
5,000 |
24,200 |
133,000 |
2.30%
0.38%
자본화:
|
볼륨(24시간):